# OnCo record tropion-breast02 (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/tropion-breast02/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "tropion-breast02", "NCT05374512" ;
  schema:name "TROPION-Breast02"@en ;
  schema:description "The first trial to show an overall survival benefit for a first-line ADC in triple-negative breast cancer."@en ;
  schema:url <https://onco.cc/trials/tropion-breast02/> ;
  schema:dateModified "2026-09-04"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT05374512>, <https://www.lbbc.org/news/pivotal-progress-in-tnbc-asco-2026>, <https://doi.org/10.1016/j.annonc.2026.03.008>, <https://api.fda.gov/drug/label.json?search=openfda.brand_name:%22DATROWAY%22> ;
  onco:status "positive" ;
  onco:phase "3" ;
  schema:startDate "2022-05-16" ;
  onco:cancers <https://onco.cc/cancers/tnbc/>, <https://onco.cc/cancers/tnbc-metastatic/> ;
  onco:technologies <https://onco.cc/technologies/adc/>, <https://onco.cc/technologies/topoisomerase-inhibitors/> ;
  onco:drugs <https://onco.cc/drugs/datopotamab-deruxtecan/> ;
  onco:companies <https://onco.cc/companies/astrazeneca/>, <https://onco.cc/companies/daiichi-sankyo/> ;
  onco:people <https://onco.cc/people/rebecca-dent/> .